Objective:
To evaluate the effectiveness of ultrawidefield optical coherence tomography angiography (OCTA) in assessing diabetic retinal disease.
Key Findings:
- OCTA is a good predictor of disease progression in diabetic retinopathy and macular edema.
- The devices allow for imaging without pupil dilation.
- Ultrawidefield OCTA captures 24-mm images in one go.
Interpretation:
The investigational OCTA devices show promise for non-invasive assessment and management of diabetic eye disease.
Limitations:
- Devices are not yet licensed in the United States.
- Data is based on investigational use and may require further validation.
Conclusion:
Ultrawidefield OCTA may significantly improve the detection and management of diabetic retinal disease.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
